Zhuang X, Wang S, Tan Y, Song J, Zhu Z, Wang Z, et al. Pharmacological enhancement of TFEB-mediated autophagy alleviated neuronal death in oxidative stress-induced Parkinson's disease models. Cell Death Dis. 2020;11:128 pubmed publisher

Barilar J, Knezovic A, Perhoc A, Homolak J, Riederer P, Salkovic Petrisic M. Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease. J Neural Transm (Vienna). 2020;127:231-250 pubmed publisher

Zhang B, Ma S, Rachmin I, He M, Baral P, Choi S, et al. Hyperactivation of sympathetic nerves drives depletion of melanocyte stem cells. Nature. 2020;577:676-681 pubmed publisher

Niedermair T, Straub R, Brochhausen C, Grassel S. Impact of the Sensory and Sympathetic Nervous System on Fracture Healing in Ovariectomized Mice. Int J Mol Sci. 2020;21: pubmed publisher

Tancheva L, Lazarova M, Alexandrova A, Dragomanova S, Nicoletti F, Tzvetanova E, et al. Neuroprotective Mechanisms of Three Natural Antioxidants on a Rat Model of Parkinson's Disease: A Comparative Study. Antioxidants (Basel). 2020;9: pubmed publisher

Heo J, Nam M, Yoon H, Kim J, Hwang Y, Won W, et al. Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson's Disease. Curr Biol. 2020;30:276-291.e9 pubmed publisher

Cai L, Tu L, Li T, Yang X, Ren Y, Gu R, et al. Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease by inhibiting SP1. Aging (Albany NY). 2020;12:672-689 pubmed publisher

Tibar H, Naudet F, Kolbl F, Ribot B, Faggiani E, N Kaoua G, et al. In vivo validation of a new portable stimulator for chronic deep brain stimulation in freely moving rats. J Neurosci Methods. 2020;333:108577 pubmed publisher

Varešlija D, Tipton K, Davey G, McDonald A. 6-Hydroxydopamine: a far from simple neurotoxin. J Neural Transm (Vienna). 2020;127:213-230 pubmed publisher

Niki T, Endo J, Takahashi Niki K, Yasuda T, Okamoto A, Saito Y, et al. DJ-1-binding compound B enhances Nrf2 activity through the PI3-kinase-Akt pathway by DJ-1-dependent inactivation of PTEN. Brain Res. 2020;1729:146641 pubmed publisher

Hadipour E, Fereidoni M, Tayarani Najaran Z. Betanin Attenuates Oxidative Stress Induced by 6-OHDA in PC12 Cells via SAPK/JNK and PI3 K Pathways. Neurochem Res. 2020;45:395-403 pubmed publisher

Koutzoumis D, Vergara M, Pino J, Buddendorff J, Khoshbouei H, Mandel R, et al. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease. Exp Neurol. 2020;325:113159 pubmed publisher

Hirata Y, Ito Y, Takashima M, Yagyu K, Oh hashi K, Suzuki H, et al. Novel Oxindole-Curcumin Hybrid Compound for Antioxidative Stress and Neuroprotection. ACS Chem Neurosci. 2020;11:76-85 pubmed publisher

Isooka N, Miyazaki I, Kikuoka R, Wada K, Nakayama E, Shin K, et al. Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes. Neurochem Int. 2020;132:104608 pubmed publisher

He W, Jing Y, Wan Q, Xiao K, Chen K, Lu Y, et al. The anatomy and metabolome of the lymphatic system in the brain in health and disease. Brain Pathol. 2020;30:392-404 pubmed publisher

Kurnik Łucka M, Latacz G, Martyniak A, Bugajski A, Kiec Kononowicz K, Gil K. Salsolinol-neurotoxic or Neuroprotective?. Neurotox Res. 2020;37:286-297 pubmed publisher

Gao J, Kang X, Sun S, Li L, Gao D. MES23.5 DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell-derived Neurotrophic Factor via Akt1/Eya1/Six2 Signaling. J Mol Neurosci. 2020;70:328-339 pubmed publisher

Kishimoto Y, Johnson J, Fang W, Halpern J, Marosi K, Liu D, et al. A mitochondrial uncoupler prodrug protects dopaminergic neurons and improves functional outcome in a mouse model of Parkinson's disease. Neurobiol Aging. 2020;85:123-130 pubmed publisher

Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, et al. Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models. J Clin Invest. 2020;130:904-920 pubmed publisher

Oliveira L, Henrique E, Bustelli I, Netto N, Moreira T, Takakura A, et al. Depletion of hypothalamic hypocretin/orexin neurons correlates with impaired memory in a Parkinson's disease animal model. Exp Neurol. 2020;323:113110 pubmed publisher

Li M, Zhu M, Xu Q, Ding F, Tian Y, Zhang M. Sensation of TRPV1 via 5-hydroxytryptamine signaling modulates pain hypersensitivity in a 6-hydroxydopamine induced mice model of Parkinson's disease. Biochem Biophys Res Commun. 2020;521:868-873 pubmed publisher

Crivelaro do Nascimento G, Ferrari D, Guimarães F, Del Bel E, Bortolanza M, Ferreira Junior N. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease. Neuropharmacology. 2020;163:107808 pubmed publisher

Mantas I, Yang Y, Mannoury La Cour C, Millan M, Zhang X, Svenningsson P. Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia. Neuropharmacology. 2020;162:107829 pubmed publisher

Xue B, Xiao W, Tian H. Nei-like 1 inhibition results in motor dysfunction and promotes inflammation in Parkinson's disease mice model. Biochem Biophys Res Commun. 2020;521:245-251 pubmed publisher

Zhu Y, Wang W, Zheng X, Chen Z, Chen T, Huang Z, et al. Characteristic response of striatal astrocytes to dopamine depletion. Neural Regen Res. 2020;15:724-730 pubmed publisher

Fine J, Stroebel B, Faltesek K, Terai K, Haase L, Knutzen K, et al. Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease. Neurosci Lett. 2020;714:134567 pubmed publisher

Giuliano C, Siani F, Mus L, Ghezzi C, Cerri S, Pacchetti B, et al. Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease. Nutrition. 2020;69:110494 pubmed publisher

Xu J, Qian Y, Wang W, Chen X, Li Y, Li Y, et al. Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease. Neural Regen Res. 2020;15:112-119 pubmed publisher

Stayte S, Laloli K, Rentsch P, Lowth A, Li K, Pickford R, et al. The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain. Exp Neurol. 2020;323:113062 pubmed publisher

Xicoy H, Brouwers J, Kalnytska O, Wieringa B, Martens G. Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson's Disease. Mol Neurobiol. 2020;57:848-859 pubmed publisher

Padovan Neto F, Patterson S, F Voelkner N, Altwal F, Beverley J, West A, et al. Selective Regulation of 5-HT1B Serotonin Receptor Expression in the Striatum by Dopamine Depletion and Repeated L-DOPA Treatment: Relationship to L-DOPA-Induced Dyskinesias. Mol Neurobiol. 2020;57:736-751 pubmed publisher

Tu L, Wu Z, Yang X, Zhang Q, Gu R, Wang Q, et al. Neuroprotective effect and mechanism of baicalin on Parkinson's disease model induced by 6-OHDA. Neuropsychiatr Dis Treat. 2019;15:3615-3625 pubmed publisher

Wang T, Ye X, Bian W, Chen Z, Du J, Li M, et al. Allopregnanolone Modulates GABAAR-Dependent CaMKIIδ3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage. Front Cell Neurosci. 2019;13:569 pubmed publisher

Fan Y, Li J, Yang Q, Gong C, Gao H, Mao Z, et al. Dysregulated Long Non-coding RNAs in Parkinson's Disease Contribute to the Apoptosis of Human Neuroblastoma Cells. Front Neurosci. 2019;13:1320 pubmed publisher

Zhai H, Kang Z, Zhang H, Ma J, Chen G. Baicalin attenuated substantia nigra neuronal apoptosis in Parkinson's disease rats via the mTOR/AKT/GSK-3β pathway. J Integr Neurosci. 2019;18:423-429 pubmed publisher

Kalyn M, Hua K, Mohd Noor S, Wong C, Ekker M. Comprehensive Analysis of Neurotoxin-Induced Ablation of Dopaminergic Neurons in Zebrafish Larvae. Biomedicines. 2019;8: pubmed publisher

Rabhi C, Arcile G, Le Goff G, Da Costa Noble C, Ouazzani J. Neuroprotective Effect of CR-777, a Glutathione Derivative of Withaferin A, Obtained through the Bioconversion of Withania somnifera (L.) Dunal Extract by the Fungus Beauveria bassiana. Molecules. 2019;24: pubmed publisher

Tsai W, Chen H, Huang Y, Chen Y, Kuo C, Chen K, et al. Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson's Disease. Behav Neurol. 2019;2019:4829572 pubmed publisher

Ogawa M, Zhou Y, Tsuji R, Kasahara J, Goto S. Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism. Front Neurol. 2019;10:1258 pubmed publisher

Soto Piña A, Franklin C, Rani C, Fernandez E, Cardoso Peña E, Benítez Arciniega A, et al. Dexamethasone Causes Hypertension in Rats Even Under Chemical Blockade of Peripheral Sympathetic Nerves. Front Neurosci. 2019;13:1305 pubmed publisher

Fletcher E, Moon L, Duty S. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease. BMC Neurosci. 2019;20:61 pubmed publisher

Khalili A, Peimani A, Safarian N, Youssef K, Zoidl G, Rezai P. Phenotypic chemical and mutant screening of zebrafish larvae using an on-demand response to electric stimulation. Integr Biol (Camb). 2019;11:373-383 pubmed publisher

Zhong X, Wang B, Zhang G, Yuan Y, Hu X, Xiong J, et al. Autophagy Activation Is Involved in Acidic Fibroblast Growth Factor Ameliorating Parkinson's Disease via Regulating Tribbles Homologue 3. Front Pharmacol. 2019;10:1428 pubmed publisher

Zhou H, Shao M, Yang X, Li C, Cui G, Gao C, et al. Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease In Vitro and In Vivo. Oxid Med Cell Longev. 2019;2019:8169125 pubmed publisher

Oliveira Giacomelli Á, M Albino C, de Souza H, Corrêa Velloso J, de Jesus Santos A, Baranova J, et al. P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson's Disease. Front Cell Neurosci. 2019;13:476 pubmed publisher

Chi H, Guan Y, Li F, Chen Z. The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model. Cell Transplant. 2019;28:87S-99S pubmed publisher

Sikora J, Kieffer B, Paoletti P, Ouagazzal A. Synaptic zinc contributes to motor and cognitive deficits in 6-hydroxydopamine mouse models of Parkinson's disease. Neurobiol Dis. 2019;134:104681 pubmed publisher

Voronin M, Kadnikov I, Voronkov D, Seredenin S. Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease. Sci Rep. 2019;9:17020 pubmed publisher

Leitner D, Ramamoorthy M, Dejosez M, Zwaka T. Immature mDA neurons ameliorate motor deficits in a 6-OHDA Parkinson's disease mouse model and are functional after cryopreservation. Stem Cell Res. 2019;41:101617 pubmed publisher

Nishiyama T, Masuda Y, Izawa T, Ohnuma T, Ogura K, Hiratsuka A. Magnolol protects PC12 cells from hydrogen peroxide or 6-hydroxydopamine induced cytotoxicity. J Toxicol Sci. 2019;44:753-758 pubmed publisher

Ko Y, Kwon S, Kim S, Lee B, Hur K, Kim Y, et al. Protective effects of 6,7,4'-trihydroxyisoflavone, a major metabolite of daidzein, on 6-hydroxydopamine-induced neuronal cell death in SH-SY5Y human neuroblastoma cells. Arch Pharm Res. 2019;42:1081-1091 pubmed publisher

Rezaee Z, Marandi S, Alaei H, Esfarjani F. The effect of preventive exercise on the neuroprotection in 6-hydroxydopamine-lesioned rat brain. Appl Physiol Nutr Metab. 2019;44:1267-1275 pubmed publisher

Ham S, Kim H, Yoon J, Kim H, Song B, Choi J, et al. Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson's Disease. Int J Mol Sci. 2019;20: pubmed publisher

Zhong H, Zhu C, Minegishi Y, Richter F, Zdunowski S, Roy R, et al. Epidural Spinal Cord Stimulation Improves Motor Function in Rats With Chemically Induced Parkinsonism. Neurorehabil Neural Repair. 2019;33:1029-1039 pubmed publisher

Zeng H, Li H, Yue M, Fan Y, Cheng J, Wu X, et al. Isoproterenol protects intestinal stem cells from chemotherapy-induced damage. Br J Pharmacol. 2019;: pubmed publisher

Hyland B, Seeger Armbruster S, Smither R, Parr Brownlie L. Altered Recruitment of Motor Cortex Neuronal Activity During the Grasping Phase of Skilled Reaching in a Chronic Rat Model of Unilateral Parkinsonism. J Neurosci. 2019;39:9660-9672 pubmed publisher

Mravec B. Chemical sympathectomy attenuates lipopolysaccharide-induced increase of plasma cytokine levels in rats pretreated by ACTH. J Neuroimmunol. 2019;337:577086 pubmed publisher

Yan T, Sun Y, Gong G, Li Y, Fan K, Wu B, et al. The neuroprotective effect of schisandrol A on 6-OHDA-induced PD mice may be related to PI3K/AKT and IKK/IκBα/NF-κB pathway. Exp Gerontol. 2019;128:110743 pubmed publisher

Wu Z, Wang T, Li L, Hui Y, Zhang Q, Yuan H. Activation and blockade of α2-adrenoceptors in the prelimbic cortex regulate anxiety-like behaviors in hemiparkinsonian rats. Biochem Biophys Res Commun. 2019;519:697-704 pubmed publisher

Lee E, Kim S, Kim C, Pagire S, Pagire H, Chung H, et al. Dopamine neuron induction and the neuroprotective effects of thyroid hormone derivatives. Sci Rep. 2019;9:13659 pubmed publisher

Kasanga E, Owens C, Cantu M, Richard A, Davis R, McDivitt L, et al. GFR-α1 Expression in Substantia Nigra Increases Bilaterally Following Unilateral Striatal GDNF in Aged Rats and Attenuates Nigral Tyrosine Hydroxylase Loss Following 6-OHDA Nigrostriatal Lesion. ACS Chem Neurosci. 2019;10:4237-4249 pubmed publisher

Mei M, Zhou Y, Liu M, Zhao F, Wang C, Ding J, et al. Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease. Neuropharmacology. 2019;160:107758 pubmed publisher

Murtazina A, Nikishina Y, Bondarenko N, Dil mukhametova L, Sapronova A, Ugrumov M. Developing brain as a source of circulating norepinephrine in rats during the critical period of morphogenesis. Brain Struct Funct. 2019;224:3059-3073 pubmed publisher

Zhang Z, Zhang X, Luan X, Wang X, Wang W, Wang X, et al. Striatal overexpression of β-arrestin2 counteracts L-dopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's disease rats. Neurochem Int. 2019;131:104543 pubmed publisher

Morales Garcia J, Alonso Gil S, Santos A, Perez Castillo A. Phosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson's Disease. Mol Neurobiol. 2019;: pubmed publisher

Giguère N, Delignat Lavaud B, Herborg F, Voisin A, Li Y, Jacquemet V, et al. Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout. PLoS Genet. 2019;15:e1008352 pubmed publisher

Bogetofte H, Jensen P, Okarmus J, Schmidt S, Agger M, Ryding M, et al. Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutation. Neurobiol Dis. 2019;132:104581 pubmed publisher

Fujikawa A, Noda Y, Yamamoto H, Tanga N, Sakaguchi G, Hattori S, et al. Mice deficient in protein tyrosine phosphatase receptor type Z (PTPRZ) show reduced responsivity to methamphetamine despite an enhanced response to novelty. PLoS ONE. 2019;14:e0221205 pubmed publisher

Ghosh B, Zhang C, Ziemba K, Fletcher A, Yurek D, Smith G. Partial Reconstruction of the Nigrostriatal Circuit along a Preformed Molecular Guidance Pathway. Mol Ther Methods Clin Dev. 2019;14:217-227 pubmed publisher

Crabbé M, Van der Perren A, Bollaerts I, Kounelis S, Baekelandt V, Bormans G, et al. Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson's Disease. Front Neurosci. 2019;13:799 pubmed publisher

Choi J, Huh E, Kim N, Kim D, Oh M. High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environment. PLoS ONE. 2019;14:e0217194 pubmed publisher

Eo H, Kwon Y, Huh E, Sim Y, Choi J, Jeong J, et al. Protective effects of DA-9805 on dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity in the models of Parkinson's disease. Biomed Pharmacother. 2019;117:109184 pubmed publisher

Hamzehloei L, Rezvani M, Rajaei Z. Effects of carvacrol and physical exercise on motor and memory impairments associated with Parkinson's disease. Arq Neuropsiquiatr. 2019;77:493-500 pubmed publisher

Han C, Guo L, Yang Y, Li W, Sheng Y, Wang J, et al. Study on antrodia camphorata polysaccharide in alleviating the neuroethology of PD mice by decreasing the expression of NLRP3 inflammasome. Phytother Res. 2019;33:2288-2297 pubmed publisher

Fernández Dueñas V, Gómez Soler M, Valle León M, Watanabe M, Ferrer I, Ciruela F. Revealing Adenosine A2A-Dopamine D2 Receptor Heteromers in Parkinson's Disease Post-Mortem Brain through a New AlphaScreen-Based Assay. Int J Mol Sci. 2019;20: pubmed publisher

Kondeva Burdina M, Voynova M, Shkondrov A, Aluani D, Tzankova V, Krasteva I. Effects of Amanita muscaria extract on different in vitro neurotoxicity models at sub-cellular and cellular levels. Food Chem Toxicol. 2019;132:110687 pubmed publisher

Lee J, Tuazon J, Corey S, Bonsack B, Acosta S, Ehrhart J, et al. A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson's Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity. Stem Cell Rev Rep. 2019;15:690-702 pubmed publisher

Lanza K, Perkins A, Deak T, Bishop C. Late aging-associated increases in L-DOPA-induced dyskinesia are accompanied by heightened neuroinflammation in the hemi-parkinsonian rat. Neurobiol Aging. 2019;81:190-199 pubmed publisher

Ahmed M, Jayakumar M, Ahmed M, Zamaleeva A, Tao J, Li E, et al. Pharmacological antagonism of histamine H2R ameliorated L-DOPA-induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PD. Neurobiol Aging. 2019;81:177-189 pubmed publisher

Cai L, Tu L, Li T, Yang X, Ren Y, Gu R, et al. Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway. Int Immunopharmacol. 2019;75:105734 pubmed publisher

Hou Y, Li X, Peng S, Yao J, Bai F, Fang J. Lipoamide Ameliorates Oxidative Stress via Induction of Nrf2/ARE Signaling Pathway in PC12 Cells. J Agric Food Chem. 2019;67:8227-8234 pubmed publisher

Huang N, Zhang Y, Chen M, Jin H, Nie J, Luo Y, et al. Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway. Exp Gerontol. 2019;124:110653 pubmed publisher

Tang S, Wang A, Yan X, Chu L, Yang X, Song Y, et al. Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease. Drug Deliv. 2019;26:700-707 pubmed publisher

Wang W, Zhang X, Lin J, Zhang Z, Wang Z, Chen S, et al. Levodopa/Benserazide PLGA Microsphere Prevents L-Dopa-Induced Dyskinesia via Lower β-Arrestin2 in 6-Hydroxydopamine Parkinson's Rats. Front Pharmacol. 2019;10:660 pubmed publisher

Iglesias González P, Conde M, Gonzalez Pardo V, Uranga R, Salvador G. In vitro 6-hydroxydopamine-induced neurotoxicity: New insights on NFκB modulation. Toxicol In Vitro. 2019;60:400-411 pubmed publisher

Rodrigues L, Oliveira L, Shinoda L, Scorza C, Faber J, Ferraz H, et al. Cardiovascular alterations in rats with Parkinsonism induced by 6-OHDA and treated with Domperidone. Sci Rep. 2019;9:8965 pubmed publisher

Shan C, Gong Y, Zhuang Q, Hou Y, Wang S, Zhu Q, et al. Protective effects of β- nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2019;94:109670 pubmed publisher

Carmo M, Gonçalves F, Canas P, Oses J, Fernandes F, Duarte F, et al. Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A2A receptor over-activation in a rat model of Parkinson's disease. Br J Pharmacol. 2019;176:3666-3680 pubmed publisher

Betharia S, Rondόn Ortiz A, Brown D. Disubstituted Dithiolethione ACDT Exerts Neuroprotective Effects Against 6-Hydroxydopamine-Induced Oxidative Stress in SH-SY5Y Cells. Neurochem Res. 2019;: pubmed publisher

Kaindlstorfer C, Stefanova N, García J, Krismer F, Döbrössy M, Göbel G, et al. L-dopa response pattern in a rat model of mild striatonigral degeneration. PLoS ONE. 2019;14:e0218130 pubmed publisher

Feng C, Chen N, Wen Z, Yang W, Kuo H, Sung P, et al. In Vitro and In Vivo Neuroprotective Effects of Stellettin B Through Anti-Apoptosis and the Nrf2/HO-1 Pathway. Mar Drugs. 2019;17: pubmed publisher

Collazo Navarrete O, Hernández García D, Guerrero Flores G, Drucker Colín R, Guerra Crespo M, Covarrubias L. THE SUBSTANTIA NIGRA IS PERMISSIVE AND GAINS INDUCTIVE SIGNALS WHEN LESIONED FOR DOPAMINERGIC DIFFERENTIATION OF EMBRYONIC STEM CELLS. Stem Cells Dev. 2019;: pubmed publisher

Hartman J, Richie C, Gordon K, Mello D, Castillo P, Zhu A, et al. MANF deletion abrogates early larval Caenorhabditis elegans stress response to tunicamycin and Pseudomonas aeruginosa. Eur J Cell Biol. 2019;: pubmed publisher

Banegas I, Segarra A, Prieto I, Vives F, de Gasparo M, Duran R, et al. Asymmetrical response of aminopeptidase A in the medial prefrontal cortex and striatum of 6-OHDA-unilaterally-lesioned Wistar Kyoto and spontaneously hypertensive rats. Pharmacol Biochem Behav. 2019;182:12-21 pubmed publisher

Bagheri Mohammadi S, Alani B, Karimian M, Moradian Tehrani R, Noureddini M. Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy. Mol Biol Rep. 2019;: pubmed publisher

Rudak P, Gangireddy R, Choi J, Burhan A, Summers K, Jackson D, et al. Stress-elicited glucocorticoid receptor signaling upregulates TIGIT in innate-like invariant T lymphocytes. Brain Behav Immun. 2019;: pubmed publisher

Meshkani S, Mahdian D, Abbaszadeh Goudarzi K, Abroudi M, Dadashizadeh G, Lalau J, et al. Metformin as a protective agent against natural or chemical toxicities: a comprehensive review on drug repositioning. J Endocrinol Invest. 2019;: pubmed publisher

Fan L, Deng B, Yan J, Hu Z, Ren A, Yang D. Lesions of mediodorsal thalamic nucleus reverse abnormal firing of the medial prefrontal cortex neurons in parkinsonian rats. Neural Regen Res. 2019;14:1635-1642 pubmed publisher

Ge H, Yan Z, Zhu H, Zhao H. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway. Exp Mol Pathol. 2019;109:16-24 pubmed publisher

Panicker N, Sarkar S, Harischandra D, Neal M, Kam T, Jin H, et al. Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia. J Exp Med. 2019;216:1411-1430 pubmed publisher

Kong Y, Cheng L, Ma L, Li H, Cheng B, Zhao Y. Norepinephrine protects against apoptosis of mesenchymal stem cells induced by high glucose. J Cell Physiol. 2019;234:20801-20815 pubmed publisher

Voronkov D, Khudoerkov R, Sal nikova O, Stavrovskaya A, Ol shanskii A, Gushchina A. Immunohistochemical Assessment of the Compensatory Responses in Rat Olfactory Bulbs after 6-Hydroxydopamine-Induced Lesion of the Substantia Nigra. Bull Exp Biol Med. 2019;166:811-815 pubmed publisher

Xu Y, Wei H, Wang J, Wang W, Gao J. Synthesis of andrographolide analogues and their neuroprotection and neurite outgrowth-promoting activities. Bioorg Med Chem. 2019;27:2209-2219 pubmed publisher

Goulding S, Sullivan A, O Keeffe G, Collins L. Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein. Parkinsonism Relat Disord. 2019;: pubmed publisher

Zygogianni O, Antoniou N, Kalomoiri M, Kouroupi G, Taoufik E, Matsas R. In Vivo Phenotyping of Familial Parkinson's Disease with Human Induced Pluripotent Stem Cells: A Proof-of-Concept Study. Neurochem Res. 2019;44:1475-1493 pubmed publisher

Sampaio T, Soares de Souza B, Roversi K, Schuh T, Poli A, Takahashi R, et al. Temporal development of behavioral impairments in rats following locus coeruleus lesion induced by 6-hydroxydopamine: Involvement of β3-adrenergic receptors. Neuropharmacology. 2019;151:98-111 pubmed publisher

Caldwell L, Davies N, Cavone L, Mysiak K, Semenova S, Panula P, et al. Regeneration of Dopaminergic Neurons in Adult Zebrafish Depends on Immune System Activation and Differs for Distinct Populations. J Neurosci. 2019;39:4694-4713 pubmed publisher

Berta B, Kertes E, Péczely L, Ollmann T, László K, Gálosi R, et al. Ventromedial prefrontal cortex is involved in preference and hedonic evaluation of tastes. Behav Brain Res. 2019;367:149-157 pubmed publisher

Park H, Zhao T, Park K, Lee M. Repeated treatments with the D1 dopamine receptor agonist SKF-38393 modulate cell viability via sustained ERK-Bad-Bax activation in dopaminergic neuronal cells. Behav Brain Res. 2019;367:166-175 pubmed publisher

Zhang Y, Huang N, Chen M, Jin H, Nie J, Shi J, et al. Procyanidin protects against 6-hydroxydopamine-induced dopaminergic neuron damage via the regulation of the PI3K/Akt signalling pathway. Biomed Pharmacother. 2019;114:108789 pubmed publisher

Keifman E, Ruiz DeDiego I, Pafundo D, Paz R, Solis O, Murer M, et al. Optostimulation of striatonigral terminals in substantia nigra induces dyskinesia that increases after L-DOPA in a mouse model of Parkinson's disease. Br J Pharmacol. 2019;176:2146-2161 pubmed publisher

Tucker H, Mahoney E, Chhetri A, Unger K, Mamone G, Kim G, et al. Deep brain stimulation of the ventroanterior and ventrolateral thalamus improves motor function in a rat model of Parkinson's disease. Exp Neurol. 2019;317:155-167 pubmed publisher

Tiefensee Ribeiro C, Gasparotto J, Petiz L, Brum P, Peixoto D, Kunzler A, et al. Oral administration of carvacrol/β-cyclodextrin complex protects against 6-hydroxydopamine-induced dopaminergic denervation. Neurochem Int. 2019;126:27-35 pubmed publisher

Gong J, Szego E, Leonov A, Benito E, Becker S, Fischer A, et al. Translocator Protein Ligand Protects against Neurodegeneration in the MPTP Mouse Model of Parkinsonism. J Neurosci. 2019;39:3752-3769 pubmed publisher

Chafik A, Essamadi A, Çelik S, Mavi A. Purification and biochemical characterization of a novel copper, zinc superoxide dismutase from liver of camel (Camelus dromedarius): An antioxidant enzyme with unique properties. Bioorg Chem. 2019;86:428-436 pubmed publisher

Oliveira L, Oliveira M, Moriya H, Moreira T, Takakura A. Respiratory disturbances in a mouse model of Parkinson's disease. Exp Physiol. 2019;104:729-739 pubmed publisher

Gomez G, Escande M, Suárez L, Rela L, Belforte J, Moratalla R, et al. Changes in Dendritic Spine Density and Inhibitory Perisomatic Connectivity onto Medium Spiny Neurons in L-Dopa-Induced Dyskinesia. Mol Neurobiol. 2019;: pubmed publisher

Körner A, Schlegel M, Kaussen T, Gudernatsch V, Hansmann G, Schumacher T, et al. Sympathetic nervous system controls resolution of inflammation via regulation of repulsive guidance molecule A. Nat Commun. 2019;10:633 pubmed publisher

Silva J, Alves C, Freitas R, Martins A, Pinteus S, Ribeiro J, et al. Antioxidant and Neuroprotective Potential of the Brown Seaweed Bifurcaria bifurcata in an in vitro Parkinson's Disease Model. Mar Drugs. 2019;17: pubmed publisher

Barrientos R, Alatorre A, Martínez Escudero J, Garcia Ramirez M, Oviedo Chávez A, Delgado A, et al. Effects of local activation and blockade of dopamine D4 receptors in the spiking activity of the reticular thalamic nucleus in normal and in ipsilateral dopamine-depleted rats. Brain Res. 2019;1712:34-46 pubmed publisher

Lin C, Tsai C. PINK1/parkin-mediated mitophagy pathway is related to neuroprotection by carnosic acid in SH-SY5Y cells. Food Chem Toxicol. 2019;125:430-437 pubmed publisher

Yao Q, Zeng Y, Feng Y, Wu H, Liang H, Gong P. Chemical Sympathectomy Impairs Peri-implant Osseointegration in Mice: Role of the Sympathetic Nervous System in Osseointegration. Int J Oral Maxillofac Implants. 2019;34:91-98 pubmed publisher

Liu X, Yan D, Guo S. Sensory nerve-derived neuropeptides accelerate the development and fibrogenesis of endometriosis. Hum Reprod. 2019;34:452-468 pubmed publisher

Zhang W, Sun C, Shao Y, Zhou Z, Hou Y, Li A. Partial depletion of dopaminergic neurons in the substantia nigra impairs olfaction and alters neural activity in the olfactory bulb. Sci Rep. 2019;9:254 pubmed publisher

Tanimura A, Du Y, Kondapalli J, Wokosin D, Surmeier D. Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson's Disease Models. Neuron. 2019;101:444-458.e6 pubmed publisher

Sellnow R, Newman J, Chambers N, West A, Steece Collier K, Sandoval I, et al. Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia. Acta Neuropathol Commun. 2019;7:8 pubmed publisher

Casarrubea M, Di Giovanni G, Crescimanno G, Rosa I, Aiello S, Di Censo D, et al. Effects of Substantia Nigra pars compacta lesion on the behavioral sequencing in the 6-OHDA model of Parkinson's disease. Behav Brain Res. 2019;362:28-35 pubmed publisher

Feng X, Yang J, Zhang X, Zhu J. Gastrointestinal non-motor dysfunction in Parkinson's disease model rats with 6-hydroxydopamine. Physiol Res. 2019;68:295-303 pubmed

Andrzejewski K, Budzinska K, Kaczynska K. Effect of 6-OHDA on hypercapnic ventilatory response in the rat model of Parkinson's disease. Physiol Res. 2019;68:285-293 pubmed

Willemze R, Welting O, van Hamersveld P, Verseijden C, Nijhuis L, Hilbers F, et al. Loss of intestinal sympathetic innervation elicits an innate immune driven colitis. Mol Med. 2019;25:1 pubmed publisher

Wang Q, Chen J, Li M, Lv S, Xie Z, Li N, et al. Eltoprazine prevents levodopa-induced dyskinesias by reducing causal interactions for theta oscillations in the dorsolateral striatum and substantia nigra pars reticulate. Neuropharmacology. 2019;148:1-10 pubmed publisher

Mishra A, Krishnamurthy S. Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson's Model in Rats. Neurotox Res. 2019;35:542-562 pubmed publisher

Patricio F, Parra I, Martinez I, Perez Severiano F, Montes S, Aguilera J, et al. Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson's Disease. Neurotox Res. 2019;35:699-710 pubmed publisher

Varmazyar R, Noori Zadeh A, Rajaei F, Darabi S, Bakhtiyari S. 17 β-Estradiol Oxidative Stress Attenuation and Autophagy-Induced Dopaminergic Neuroprotection. Cell J. 2019;21:1-6 pubmed publisher

Liew K, Lee E, Chan K, Lee C. Multi-targeting aurones with monoamine oxidase and amyloid-beta inhibitory activities: Structure-activity relationship and translating multi-potency to neuroprotection. Biomed Pharmacother. 2019;110:118-128 pubmed publisher

Gonçalves D, Courtes A, Hartmann D, da Rosa P, Oliveira D, Soares F, et al. 6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat. Neurotoxicology. 2019;70:1-11 pubmed publisher

Ganapathy K, Datta I, Bhonde R. Astrocyte-Like Cells Differentiated from Dental Pulp Stem Cells Protect Dopaminergic Neurons Against 6-Hydroxydopamine Toxicity. Mol Neurobiol. 2019;56:4395-4413 pubmed publisher

Lai C, Lu C, Lin H, Sung Y, Wu Y, Hong J, et al. Valproate is protective against 6-OHDA-induced dopaminergic neurodegeneration in rodent midbrain: A potential role of BDNF up-regulation. J Formos Med Assoc. 2019;118:420-428 pubmed publisher

Nakashima A, Yamauchi A, Matsumoto J, Dohgu S, Takata F, Koga M, et al. Feeding-produced subchronic high plasma levels of uric acid improve behavioral dysfunction in 6-hydroxydopamine-induced mouse model of Parkinson's disease. Behav Pharmacol. 2019;30:89-94 pubmed publisher

Kaddour H, Hamdi Y, Amri F, Bahdoudi S, Bouannee I, Leprince J, et al. Antioxidant and Anti-Apoptotic Activity of Octadecaneuropeptide Against 6-OHDA Toxicity in Cultured Rat Astrocytes. J Mol Neurosci. 2018;: pubmed publisher

Parga J, Rodriguez Perez A, García Garrote M, Rodriguez Pallares J, Labandeira Garcia J. Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells. Free Radic Biol Med. 2018;129:394-406 pubmed publisher

Mendes Pinheiro B, Teixeira F, Anjo S, Manadas B, Behie L, Salgado A. Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease. Stem Cells Transl Med. 2018;7:829-838 pubmed publisher

Urano Y, Mori C, Fuji A, Konno K, Yamamoto T, Yashirogi S, et al. 6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway. Autophagy. 2018;14:1943-1958 pubmed publisher

Oliveira L, Falquetto B, Moreira T, Takakura A. Orexinergic neurons are involved in the chemosensory control of breathing during the dark phase in a Parkinson's disease model. Exp Neurol. 2018;309:107-118 pubmed publisher

Li J, Sun Y, Chen J. Identification of Critical Genes and miRNAs Associated with the Development of Parkinson's Disease. J Mol Neurosci. 2018;65:527-535 pubmed publisher

Nakhaeifard M, Haji Ghasem Kashani M, Goudarzi I, Rezaei A. Conditioned Medium Protects Dopaminergic Neurons in Parkinsonian Rats. Cell J. 2018;20:348-354 pubmed publisher

Leem E, Kim H, Choi M, Kim S, Oh Y, Lee K, et al. Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo. Cell Death Dis. 2018;9:449 pubmed publisher

Silva J, Alves C, Pinteus S, Mendes S, Pedrosa R. Neuroprotective effects of seaweeds against 6-hydroxidopamine-induced cell death on an in vitro human neuroblastoma model. BMC Complement Altern Med. 2018;18:58 pubmed publisher

Moon H, Jang J, Jang T, Park G. Carbon Monoxide Ameliorates 6-Hydroxydopamine-Induced Cell Death in C6 Glioma Cells. Biomol Ther (Seoul). 2018;26:175-181 pubmed publisher

West T, Berthouze L, Halliday D, Litvak V, Sharott A, Magill P, et al. Propagation of beta/gamma rhythms in the cortico-basal ganglia circuits of the parkinsonian rat. J Neurophysiol. 2018;119:1608-1628 pubmed publisher

Aparicio Juárez A, Duhne M, Lara González E, Ávila Cascajares F, Calderón V, Galarraga E, et al. Cortical stimulation relieves Parkinsonian pathological activity in vitro. Eur J Neurosci. 2017;: pubmed publisher

Morales I, Sánchez A, Rodriguez Sabate C, Rodriguez M. Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model. PLoS ONE. 2017;12:e0185989 pubmed publisher

Valdman E, Kapitsa I, Ivanova Е, Voronina T, Ardashov O, Volcho K, et al. Evolution of anti-parkinsonian activity of monoterpenoid (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in various in vivo models. Eur J Pharmacol. 2017;815:351-363 pubmed publisher

Park S, Song S, Palmateer B, Pal A, Petersen E, Shall G, et al. Novel luciferase-opsin combinations for improved luminopsins. J Neurosci Res. 2017;: pubmed publisher

Oliveira L, Tuppy M, Moreira T, Takakura A. Role of the locus coeruleus catecholaminergic neurons in the chemosensory control of breathing in a Parkinson's disease model. Exp Neurol. 2017;293:172-180 pubmed publisher

Andrzejewski K, Kaczynska K, Zaremba M. Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson's disease. J Biomed Sci. 2017;24:24 pubmed publisher

Stępkowski T, Męczyńska Wielgosz S, Kruszewski M. mitoLUHMES: An Engineered Neuronal Cell Line for the Analysis of the Motility of Mitochondria. Cell Mol Neurobiol. 2017;37:1055-1066 pubmed publisher

Lorenc Koci E, Czarnecka A, Kamińska K, Knutelska J, Zygmunt M, Dudek M. Contribution of the nitric oxide donor molsidomine and the antiparkinsonian drug l-DOPA to the modulation of the blood pressure in unilaterally 6-OHDA-lesioned rats. Pharmacol Rep. 2017;69:29-35 pubmed publisher

Liang J, Wang L, He J, Hua X. Verbascoside promotes the regeneration of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra. Neural Regen Res. 2016;11:101-6 pubmed publisher

Serratos I, Castellanos P, Pastor N, Millán Pacheco C, Colín González A, Rembao D, et al. Early expression of the receptor for advanced glycation end products in a toxic model produced by 6-hydroxydopamine in the rat striatum. Chem Biol Interact. 2016;249:10-8 pubmed publisher

Hoffmann L, Saravanan V, Wood A, He L, Sober S. Dopaminergic Contributions to Vocal Learning. J Neurosci. 2016;36:2176-89 pubmed publisher

Bang J, Jung I, Song Y, Park H, Moon B, Lee B, et al. PET imaging of dopamine transporters with [(18)F]FE-PE2I: Effects of anti-Parkinsonian drugs. Nucl Med Biol. 2016;43:158-64 pubmed publisher

Aristieta A, Ruiz Ortega J, Miguelez C, Morera Herreras T, Ugedo L. Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats. Neurobiol Dis. 2016;89:88-100 pubmed publisher

Kuter K, Kratochwil M, Berghauzen Maciejewska K, Głowacka U, Sugawa M, Ossowska K, et al. Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson's disease. Biochim Biophys Acta. 2016;1862:741-753 pubmed publisher

Tseng W, Hsu Y, Pan T. The ameliorative effect of Monascus purpureus NTU 568-fermented rice extracts on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and the rat model of Parkinson's disease. Food Funct. 2016;7:752-62 pubmed publisher

Li L, Gao L, Song Y, Qin Z, Liang Z. Activated cathepsin L is associated with the switch from autophagy to apoptotic death of SH-SY5Y cells exposed to 6-hydroxydopamine. Biochem Biophys Res Commun. 2016;470:579-585 pubmed publisher

Sun X, Shi X, Lu L, Jiang Y, Liu B. Stimulus-dependent neuronal cell responses in SH-SY5Y neuroblastoma cells. Mol Med Rep. 2016;13:2215-20 pubmed publisher

Tao K, Wang B, Feng D, Zhang W, Lu F, Lai J, et al. Salidroside Protects Against 6-Hydroxydopamine-Induced Cytotoxicity by Attenuating ER Stress. Neurosci Bull. 2016;32:61-9 pubmed publisher

Song P, Li S, Wu H, Gao R, Rao G, Wang D, et al. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease. Protein Cell. 2016;7:114-29 pubmed publisher

Machado V, Haas S, Von Bohlen Und Halbach O, Wree A, Krieglstein K, Unsicker K, et al. Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiol Dis. 2016;88:1-15 pubmed publisher

Li C, Zhang Y, Yang C, Hao F, Chen S, Hao Q, et al. Intraventricular administration of endoneuraminidase-N facilitates ectopic migration of subventricular zone-derived neural progenitor cells into 6-OHDA lesioned striatum of mice. Exp Neurol. 2016;277:139-149 pubmed publisher

Szpunar M, Belcher E, Dawes R, Madden K. Sympathetic innervation, norepinephrine content, and norepinephrine turnover in orthotopic and spontaneous models of breast cancer. Brain Behav Immun. 2016;53:223-233 pubmed publisher

Matheus F, Rial D, Real J, Lemos C, Ben J, Guaita G, et al. Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats. Behav Brain Res. 2016;301:43-54 pubmed publisher

Kwak C, Lim C, Kaang B. Assessments of cognitive abilities in a mouse model of Parkinson's disease with a touch screen test. Behav Brain Res. 2016;301:63-71 pubmed publisher

Sagarduy A, Llorente J, Miguelez C, Morera Herreras T, Ruiz Ortega J, Ugedo L. Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors. Exp Neurol. 2016;277:35-45 pubmed publisher

Ma C, Pan Y, Yang Z, Meng Z, Sun R, Wang T, et al. Pre-administration of BAX-inhibiting peptides decrease the loss of the nigral dopaminergic neurons in rats. Life Sci. 2016;144:113-20 pubmed publisher

Yang J, Hertz E, Zhang X, Leinartaité L, Lundius E, Li J, et al. Overexpression of α-synuclein simultaneously increases glutamate NMDA receptor phosphorylation and reduces glucocerebrosidase activity. Neurosci Lett. 2016;611:51-8 pubmed publisher

Tsuchioka A, Oana F, Suzuki T, Yamauchi Y, Ijiro T, Kaidoh K, et al. Duration of drug action of dopamine D2 agonists in mice with 6-hydroxydopamine-induced lesions. Neuroreport. 2015;26:1126-32 pubmed publisher

Divito C, Steece Collier K, Case D, Williams S, Stancati J, Zhi L, et al. Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease. J Neurosci. 2015;35:14983-99 pubmed publisher

Murata H, Takamatsu H, Liu S, Kataoka K, Huh N, Sakaguchi M. NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions. PLoS ONE. 2015;10:e0142438 pubmed publisher

Dong Y, Liu G, Wang Z, Li J, Cao J, Chen Y. Effects of catecholaminergic nerve lesion on endometrial development during early pregnancy in Mice. Histol Histopathol. 2016;31:415-24 pubmed publisher

Hajj R, Milet A, Toulorge D, Cholet N, Laffaire J, Foucquier J, et al. Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease. Sci Rep. 2015;5:16084 pubmed publisher

Pfister D, Yu C, Kim D, Li J, Drewing A, Li L. Zebrafish Olfacto-Retinal Centrifugal Axon Projection and Distribution: Effects of Gonadotropin-Releasing Hormone and Dopaminergic Signaling. Dev Neurosci. 2016;38:27-33 pubmed publisher

Li Q, Zhang L, Wan H, Liu M, Li X, Tang H. CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells. Oncotarget. 2015;6:34924-40 pubmed publisher

Ndlovu B, Daniels W, Mabandla M. Amelioration of L-Dopa-Associated Dyskinesias with Triterpenoic Acid in a Parkinsonian Rat Model. Neurotox Res. 2016;29:126-34 pubmed publisher

Kreipke R, Birren S. Innervating sympathetic neurons regulate heart size and the timing of cardiomyocyte cell cycle withdrawal. J Physiol. 2015;593:5057-73 pubmed publisher

Tristão F, Lazzarini M, Martin S, Amar M, Stühmer W, Kirchhoff F, et al. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration. Neurotox Res. 2016;29:364-80 pubmed publisher

Hou X, Si J, Ren H, Chen D, Wang H, Ying Z, et al. Parkin represses 6-hydroxydopamine-induced apoptosis via stabilizing scaffold protein p62 in PC12 cells. Acta Pharmacol Sin. 2015;36:1300-7 pubmed publisher

Castillo V, Oñate M, Woehlbier U, Rozas P, Andreu C, Medinas D, et al. Functional Role of the Disulfide Isomerase ERp57 in Axonal Regeneration. PLoS ONE. 2015;10:e0136620 pubmed publisher

Aguiar A, Duzzioni M, Remor A, Tristão F, Matheus F, Raisman Vozari R, et al. Moderate-Intensity Physical Exercise Protects Against Experimental 6-Hydroxydopamine-Induced Hemiparkinsonism Through Nrf2-Antioxidant Response Element Pathway. Neurochem Res. 2016;41:64-72 pubmed publisher

Chattopadhyaya I, Gupta S, Mohammed A, Mushtaq N, Chauhan S, Ghosh S, et al. Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats. BMC Complement Altern Med. 2015;15:296 pubmed publisher

Thomas M, Welch C, Stone L, Allan P, Barker R, White R. PAX6 expression may be protective against dopaminergic cell loss in Parkinson's disease. CNS Neurol Disord Drug Targets. 2016;15:73-9 pubmed

Ba Q, Cui C, Wen L, Feng S, Zhou J, Yang K. Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson's disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway. Biomed Pharmacother. 2015;75:165-72 pubmed publisher

Virel A, Rehnmark A, Orädd G, Olmedo Díaz S, Faergemann E, Stromberg I. Magnetic resonance imaging as a tool to image neuroinflammation in a rat model of Parkinson's disease--phagocyte influx to the brain is promoted by bilberry-enriched diet. Eur J Neurosci. 2015;42:2761-71 pubmed publisher

Aimé P, Sun X, Zareen N, Rao A, Berman Z, Volpicelli Daley L, et al. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models. J Neurosci. 2015;35:10731-49 pubmed publisher

Fischer D, Collier T, Cole Strauss A, Wohlgenant S, Lipton J, Steece Collier K, et al. High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine. PLoS ONE. 2015;10:e0133957 pubmed publisher

Kim D, Lee I, Nam S, Hong J, Zhang P, Lu L, et al. Antimicrobial Peptide, Lumbricusin, Ameliorates Motor Dysfunction and Dopaminergic Neurodegeneration in a Mouse Model of Parkinson's Disease. J Microbiol Biotechnol. 2015;25:1640-7 pubmed publisher

Hernandez Chan N, Bannon M, Orozco Barrios C, Escobedo L, Zamudio S, De La Cruz F, et al. Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease. J Biomed Sci. 2015;22:59 pubmed publisher

Furlanetti L, Coenen V, Aranda I, Döbrössy M. Chronic deep brain stimulation of the medial forebrain bundle reverses depressive-like behavior in a hemiparkinsonian rodent model. Exp Brain Res. 2015;233:3073-85 pubmed publisher

Ning X, Yuan M, Guo Y, Tian C, Wang X, Zhang Z, et al. Neuroprotective effects of (E)-3,4-diacetoxystyryl sulfone and sulfoxide derivatives in vitro models of Parkinson's disease. J Enzyme Inhib Med Chem. 2016;31:464-9 pubmed publisher

Yang X, Zhao E, Zhuang W, Sun F, Han H, Han H, et al. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease. Neurol Sci. 2015;36:2027-33 pubmed publisher

Panicker N, Saminathan H, Jin H, Neal M, Harischandra D, Gordon R, et al. Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease. J Neurosci. 2015;35:10058-77 pubmed publisher

Xiao J, Yin M, Wang Z, Wang X. Transplanted Neural Stem Cells: Playing a Neuroprotective Role by Ceruloplasmin in the Substantia Nigra of PD Model Rats?. Oxid Med Cell Longev. 2015;2015:618631 pubmed publisher

Nakadate K, Tanaka Nakadate S. Three-Dimensional Electron Microscopy Reconstruction of Degenerative Dopaminergic Neurons Surrounded by Activated Microglia in Substantia Nigra. Ultrastruct Pathol. 2015;39:369-77 pubmed publisher

Mao S, Sun Q, Xiao H, Zhang C, Li L. Secreted miR-34a in astrocytic shedding vesicles enhanced the vulnerability of dopaminergic neurons to neurotoxins by targeting Bcl-2. Protein Cell. 2015;6:529-540 pubmed publisher

Lee M, Ryu Y, Cho W, Kang Y, Lee S, Jeon T, et al. Relationship between dopamine deficit and the expression of depressive behavior resulted from alteration of serotonin system. Synapse. 2015;69:453-60 pubmed publisher

Liu H, Mao P, Wang J, Wang T, Xie C. Allicin Protects PC12 Cells Against 6-OHDA-Induced Oxidative Stress and Mitochondrial Dysfunction via Regulating Mitochondrial Dynamics. Cell Physiol Biochem. 2015;36:966-79 pubmed publisher

Höglinger G, Alvarez Fischer D, Arias Carrión O, Djufri M, Windolph A, Keber U, et al. A new dopaminergic nigro-olfactory projection. Acta Neuropathol. 2015;130:333-48 pubmed publisher

Requejo C, Ruiz Ortega J, Bengoetxea H, Garcia Blanco A, Herrán E, Aristieta A, et al. Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration. Mol Neurobiol. 2015;52:846-58 pubmed publisher

Peng S, Zhang B, Yao J, Duan D, Fang J. Dual protection of hydroxytyrosol, an olive oil polyphenol, against oxidative damage in PC12 cells. Food Funct. 2015;6:2091-100 pubmed publisher

Ju C, Hou L, Sun F, Zhang L, Zhang Z, Gao H, et al. Anti-oxidation and Antiapoptotic Effects of Chondroitin Sulfate on 6-Hydroxydopamine-Induced Injury Through the Up-Regulation of Nrf2 and Inhibition of Mitochondria-Mediated Pathway. Neurochem Res. 2015;40:1509-19 pubmed publisher

Lev N, Barhum Y, Ben Zur T, Aharony I, Trifonov L, Regev N, et al. A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2. PLoS ONE. 2015;10:e0127549 pubmed publisher

Chiu C, Li I, Weng S, Huang Y, Wu S, Chou T, et al. PET Imaging of Serotonin Transporters With 4-[(18)F]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts. Cell Transplant. 2016;25:301-11 pubmed publisher

Kanaan N, Collier T, Cole Strauss A, Grabinski T, Mattingly Z, Winn M, et al. The longitudinal transcriptomic response of the substantia nigra to intrastriatal 6-hydroxydopamine reveals significant upregulation of regeneration-associated genes. PLoS ONE. 2015;10:e0127768 pubmed publisher

Morales I, Sánchez A, Rodriguez Sabate C, Rodriguez M. The degeneration of dopaminergic synapses in Parkinson's disease: A selective animal model. Behav Brain Res. 2015;289:19-28 pubmed publisher

Ferrigno A, Vairetti M, Ambrosi G, Rizzo V, Richelmi P, Blandini F, et al. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats. Clin Exp Pharmacol Physiol. 2015;42:695-703 pubmed publisher

Stayte S, Rentsch P, Li K, Vissel B. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease. PLoS ONE. 2015;10:e0124325 pubmed publisher

Mai B, Hauber W. Orbitofrontal or accumbens dopamine depletion does not affect risk-based decision making in rats. Cogn Affect Behav Neurosci. 2015;15:507-22 pubmed publisher

Iqbal S, Howard S, LoGrasso P. Serum- and Glucocorticoid-Inducible Kinase 1 Confers Protection in Cell-Based and in In Vivo Neurotoxin Models via the c-Jun N-Terminal Kinase Signaling Pathway. Mol Cell Biol. 2015;35:1992-2006 pubmed publisher

Lin J, Peng Y, Wang S, Young T, Salter D, Lee H. Role of the sympathetic nervous system in carbon tetrachloride-induced hepatotoxicity and systemic inflammation. PLoS ONE. 2015;10:e0121365 pubmed publisher

Ozsoy O, Yildirim F, Oğüt E, Kaya Y, Tanriover G, Parlak H, et al. Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model. Free Radic Res. 2015;49:1004-14 pubmed publisher

Abdallah K, Monconduit L, Artola A, Luccarini P, Dallel R. GABAAergic inhibition or dopamine denervation of the A11 hypothalamic nucleus induces trigeminal analgesia. Pain. 2015;156:644-55 pubmed publisher

Wang T, Cao X, Zhang T, Shi Q, Chen Z, Tang B. Effect of simvastatin on L-DOPA-induced abnormal involuntary movements of hemiparkinsonian rats. Neurol Sci. 2015;36:1397-402 pubmed publisher

Stojkovska I, Wagner B, Morrison B. Parkinson's disease and enhanced inflammatory response. Exp Biol Med (Maywood). 2015;240:1387-95 pubmed publisher

Bundzikova Osacka J, Ghosal S, Packard B, Ulrich Lai Y, Herman J. Role of nucleus of the solitary tract noradrenergic neurons in post-stress cardiovascular and hormonal control in male rats. Stress. 2015;18:221-32 pubmed publisher

Mitra R, Aronsson P, Winder M, Tobin G, Bergquist F, Carlsson T. Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson's Disease. J Parkinsons Dis. 2015;5:301-11 pubmed publisher

Razgado Hernandez L, Espadas Alvarez A, Reyna Velazquez P, Sierra Sánchez A, Anaya Martinez V, Jiménez Estrada I, et al. The transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's disease. PLoS ONE. 2015;10:e0117391 pubmed publisher

Wang J, Bi M, Xie J. Ceruloplasmin is Involved in the Nigral Iron Accumulation of 6-OHDA-Lesioned Rats. Cell Mol Neurobiol. 2015;35:661-8 pubmed publisher

Zheng T, Lv Q, Lei X, Yin X, Zhang B. Spatial distribution of 5-hydroxymethyl cytosine in rat brain and temporal distribution in striatum. Neurochem Res. 2015;40:688-97 pubmed publisher

In S, Hong C, Choi B, Jang B, Kim M. Inhibition of Mitochondrial Clearance and Cu/Zn-SOD Activity Enhance 6-Hydroxydopamine-Induced Neuronal Apoptosis. Mol Neurobiol. 2016;53:777-791 pubmed publisher

Wu X, Li Y, Zhang P, Qian K, Ding J, Hu G, et al. Unaltered retinal dopamine levels in a C57BL/6 mouse model of form-deprivation myopia. Invest Ophthalmol Vis Sci. 2015;56:967-77 pubmed publisher

Zou H, Limpert A, Zou J, Dembo A, Lee P, Grant D, et al. Benzodiazepinone derivatives protect against endoplasmic reticulum stress-mediated cell death in human neuronal cell lines. ACS Chem Neurosci. 2015;6:464-75 pubmed publisher

Marei H, Lashen S, Farag A, Althani A, Afifi N, A A, et al. Human olfactory bulb neural stem cells mitigate movement disorders in a rat model of Parkinson's disease. J Cell Physiol. 2015;230:1614-29 pubmed publisher

Nadella R, Voutilainen M, Saarma M, Gonzalez Barrios J, Leon Chavez B, Jiménez J, et al. Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra. J Neuroinflammation. 2014;11:209 pubmed publisher

Bar Am O, Amit T, Kupershmidt L, Aluf Y, Mechlovich D, Kabha H, et al. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging. Neurobiol Aging. 2015;36:1529-42 pubmed publisher

Jia W, Xu H, Du X, Jiang H, Xie J. Ndfip1 attenuated 6-OHDA-induced iron accumulation via regulating the degradation of DMT1. Neurobiol Aging. 2015;36:1183-93 pubmed publisher

Iacovitti L, Wei X, Cai J, Kostuk E, Lin R, Gorodinsky A, et al. The hTH-GFP reporter rat model for the study of Parkinson's disease. PLoS ONE. 2014;9:e113151 pubmed publisher

Morales Garcia J, Aguilar Morante D, Hernández Encinas E, Alonso Gil S, Gil C, Martinez A, et al. Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice. Neurobiol Aging. 2015;36:1160-73 pubmed publisher

Wu C, Chang S, Lin C, Huang L, Tsai C. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. Chem Biol Interact. 2015;225:40-6 pubmed publisher

Rodriguez Perez A, Borrajo A, Valenzuela R, Lanciego J, Labandeira Garcia J. Critical period for dopaminergic neuroprotection by hormonal replacement in menopausal rats. Neurobiol Aging. 2015;36:1194-208 pubmed publisher

Bosch Bouju C, Smither R, Hyland B, Parr Brownlie L. Reduced reach-related modulation of motor thalamus neural activity in a rat model of Parkinson's disease. J Neurosci. 2014;34:15836-50 pubmed publisher

Huang L, Deng M, He Y, Fang Y. β-asarone and levodopa co-administration protects against 6-hydroxydopamine-induced damage in parkinsonian rat mesencephalon by regulating autophagy: down-expression Beclin-1 and light chain 3B and up-expression P62. Clin Exp Pharmacol Physiol. 2015;42:269-77 pubmed publisher

Yoon H, Kim Y, Shin E, Jeon S. A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum. J Korean Med Sci. 2014;29:1555-61 pubmed publisher

Zhang F, He Y, Zheng Y, Zhang W, Wang Q, Jia Y, et al. Therapeutic effects of fucoidan in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: Role of NADPH oxidase-1. CNS Neurosci Ther. 2014;20:1036-44 pubmed publisher

Zheng K, Iqbal S, Hernandez P, Park H, LoGrasso P, Feng Y. Design and synthesis of highly potent and isoform selective JNK3 inhibitors: SAR studies on aminopyrazole derivatives. J Med Chem. 2014;57:10013-30 pubmed publisher

Fieblinger T, Graves S, Sebel L, Alcacer C, Plotkin J, Gertler T, et al. Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia. Nat Commun. 2014;5:5316 pubmed publisher

Xu Z, Wang W, Liang X, Liu Z, Liu Y, Lin L, et al. Protective effects of poly (butyl) cyanoacrylate nanoparticles containing vasoactive intestinal peptide against 6-hydroxydopamine-induced neurotoxicity in vitro. J Mol Neurosci. 2015;55:854-64 pubmed publisher

Xu L, Yu W, Lin Z, Tan S, Bai X, Ding K, et al. Chemical sympathectomy attenuates inflammation, glycocalyx shedding and coagulation disorders in rats with acute traumatic coagulopathy. Blood Coagul Fibrinolysis. 2015;26:152-60 pubmed publisher

Yildirim F, Ozsoy O, Tanriover G, Kaya Y, Ogut E, Gemici B, et al. Mechanism of the beneficial effect of melatonin in experimental Parkinson's disease. Neurochem Int. 2014;79:1-11 pubmed publisher

Bordia T, McGregor M, Papke R, Decker M, McIntosh J, Quik M. The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions. Exp Neurol. 2015;263:277-84 pubmed publisher

Meng X, Zheng R, Zhang Y, Qiao M, Liu L, Jing P, et al. An activated sympathetic nervous system affects white adipocyte differentiation and lipolysis in a rat model of Parkinson's disease. J Neurosci Res. 2015;93:350-60 pubmed publisher

Han B, Jin H, Song M, Wang T, Zhao H. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions. Parkinsonism Relat Disord. 2014;20:1191-5 pubmed publisher

Stansley B, Yamamoto B. Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus. J Pharmacol Exp Ther. 2014;351:440-7 pubmed publisher

Lindenbach D, Palumbo N, Ostock C, Vilceus N, Conti M, Bishop C. Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats. Br J Pharmacol. 2015;172:119-30 pubmed publisher

Mango D, Bonito Oliva A, Ledonne A, Cappellacci L, Petrelli R, Nisticò R, et al. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice. Exp Neurol. 2014;261:733-43 pubmed publisher

Muñoz Manchado A, Foldi C, Szydlowski S, Sjulson L, Farries M, Wilson C, et al. Novel Striatal GABAergic Interneuron Populations Labeled in the 5HT3a(EGFP) Mouse. Cereb Cortex. 2016;26:96-105 pubmed publisher

Berg J, Roch M, Altschüler J, Winter C, Schwerk A, Kurtz A, et al. Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory f. Stem Cell Rev Rep. 2015;11:133-49 pubmed publisher

Tatenhorst L, Tönges L, Saal K, Koch J, Szego E, Bahr M, et al. Rho kinase inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease. J Neuropathol Exp Neurol. 2014;73:770-9 pubmed publisher

Zhao R, Lu W, Fang X, Guo L, Yang Z, Ye N, et al. (6aR)-11-amino-N-propyl-noraporphine, a new dopamine D2 and serotonin 5-HT1A dual agonist, elicits potent antiparkinsonian action and attenuates levodopa-induced dyskinesia in a 6-OHDA-lesioned rat model of Parkinson's disease. Pharmacol Biochem Behav. 2014;124:204-10 pubmed publisher

Tripathy D, Verma P, Nthenge Ngumbau D, Banerjee M, Mohanakumar K. Regenerative therapy in experimental parkinsonism: mixed population of differentiated mouse embryonic stem cells, rather than magnetically sorted and enriched dopaminergic cells provide neuroprotection. CNS Neurosci Ther. 2014;20:717-27 pubmed publisher

Summerson S, Aazhang B, Kemere C. Characterizing motor and cognitive effects associated with deep brain stimulation in the GPi of hemi-Parkinsonian rats. IEEE Trans Neural Syst Rehabil Eng. 2014;22:1218-27 pubmed publisher

Liu X, Shao R, Li M, Yang G. Edaravone protects neurons in the rat substantia nigra against 6-hydroxydopamine-induced oxidative stress damage. Cell Biochem Biophys. 2014;70:1247-54 pubmed publisher

Révy D, Jaouen F, Salin P, Melon C, Chabbert D, Tafi E, et al. Cellular and behavioral outcomes of dorsal striatonigral neuron ablation: new insights into striatal functions. Neuropsychopharmacology. 2014;39:2662-72 pubmed publisher

Clarke H, Cardinal R, Rygula R, Hong Y, Fryer T, Sawiak S, et al. Orbitofrontal dopamine depletion upregulates caudate dopamine and alters behavior via changes in reinforcement sensitivity. J Neurosci. 2014;34:7663-76 pubmed publisher

Shah M, Rajagopalan S, Xu L, Voshavar C, Shurubor Y, Beal F, et al. The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease. J Neurochem. 2014;131:74-85 pubmed publisher

Sullivan R, Dufresne M, Siontas D, Chehab S, Townsend J, Laplante F. Mesocortical dopamine depletion and anxiety-related behavior in the rat: sex and hemisphere differences. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:59-66 pubmed publisher

Kwon S, Ma S, Lee S, Jang C. Sulfuretin inhibits 6-hydroxydopamine-induced neuronal cell death via reactive oxygen species-dependent mechanisms in human neuroblastoma SH-SY5Y cells. Neurochem Int. 2014;74:53-64 pubmed publisher

Patel V, Chu C. Decreased SIRT2 activity leads to altered microtubule dynamics in oxidatively-stressed neuronal cells: implications for Parkinson's disease. Exp Neurol. 2014;257:170-81 pubmed publisher

Francardo V, Bez F, Wieloch T, Nissbrandt H, Ruscher K, Cenci M. Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. Brain. 2014;137:1998-2014 pubmed publisher

Oeckl P, Hengerer B, Ferger B. G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease. Exp Neurol. 2014;257:1-9 pubmed publisher

Shin E, Rogers J, Devoto P, Bjorklund A, Carta M. Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Exp Neurol. 2014;257:25-38 pubmed publisher

Czech D, Lee J, Correia J, Loke H, Möller E, Harley V. Transient neuroprotection by SRY upregulation in dopamine cells following injury in males. Endocrinology. 2014;155:2602-12 pubmed publisher

Kupsch A, Schmidt W, Gizatullina Z, Debska Vielhaber G, Voges J, Striggow F, et al. 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses. J Neural Transm (Vienna). 2014;121:1245-57 pubmed publisher

Karuppagounder S, Bhattacharya D, Ahuja M, Suppiramaniam V, Deruiter J, Clark R, et al. Elucidating the neurotoxic effects of MDMA and its analogs. Life Sci. 2014;101:37-42 pubmed publisher

Suzuki Y, Shimizu H, Ishizuka N, Kubota N, Kubota T, Senoo A, et al. Vagal hyperactivity due to ventromedial hypothalamic lesions increases adiponectin production and release. Diabetes. 2014;63:1637-48 pubmed publisher

Zhang X, Feng Z, Chergui K. GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease. J Neurochem. 2014;129:581-90 pubmed publisher

Song J, Zheng L, Zhang X, Feng X, Fan R, Sun L, et al. Upregulation of ?1-adrenoceptors is involved in the formation of gastric dysmotility in the 6-hydroxydopamine rat model of Parkinson's disease. Transl Res. 2014;164:22-31 pubmed publisher

Hsieh T, Huang Y, Rotenberg A, Pascual Leone A, Chiang Y, Wang J, et al. Functional Dopaminergic Neurons in Substantia Nigra are Required for Transcranial Magnetic Stimulation-Induced Motor Plasticity. Cereb Cortex. 2015;25:1806-14 pubmed publisher

Salvatore M. ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion. J Neurochem. 2014;129:548-58 pubmed publisher

Lin L, Moore S, Jones S, McGlashon J, Talman W. Astrocytes in the rat nucleus tractus solitarii are critical for cardiovascular reflex control. J Neurosci. 2013;33:18608-17 pubmed publisher

Unal B, Shah F, Kothari J, Tepper J. Anatomical and electrophysiological changes in striatal TH interneurons after loss of the nigrostriatal dopaminergic pathway. Brain Struct Funct. 2015;220:331-49 pubmed publisher

Liu Y, Peng M, Zang D, Zhang B. Leukemia inhibitory factor promotes nestin-positive cells, and increases gp130 levels in the Parkinson disease mouse model of 6-hydroxydopamine. Neurosciences (Riyadh). 2013;18:363-70 pubmed

Schmitz Y, Castagna C, Mrejeru A, Lizardi Ortiz J, Klein Z, Lindsley C, et al. Glycine transporter-1 inhibition promotes striatal axon sprouting via NMDA receptors in dopamine neurons. J Neurosci. 2013;33:16778-89 pubmed publisher

Kucinski A, Paolone G, Bradshaw M, Albin R, Sarter M. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation. J Neurosci. 2013;33:16522-39 pubmed publisher

Fan Y, Li J, Zhang Y, Jiang L, Zhang Y, Yan C. Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells. Neurol Res. 2014;36:53-64 pubmed publisher

Haddadi R, Mohajjel Nayebi A, Brooshghalan S. Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats. Neurosci Lett. 2013;555:106-11 pubmed publisher

Chu C, Ji J, Dagda R, Jiang J, Tyurina Y, Kapralov A, et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol. 2013;15:1197-1205 pubmed publisher

Chetrit J, Taupignon A, Froux L, Morin S, Bouali Benazzouz R, Naudet F, et al. Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease. J Neurosci. 2013;33:14840-9 pubmed publisher

Wang M, Tanida M, Shibamoto T, Kurata Y. Alpha-adrenoceptor antagonists and chemical sympathectomy exacerbate anaphylaxis-induced hypotension, but not portal hypertension, in anesthetized rats. Am J Physiol Regul Integr Comp Physiol. 2013;305:R900-7 pubmed publisher

Meesarapee B, Thampithak A, Jaisin Y, Sanvarinda P, Suksamrarn A, Tuchinda P, et al. Curcumin I mediates neuroprotective effect through attenuation of quinoprotein formation, p-p38 MAPK expression, and caspase-3 activation in 6-hydroxydopamine treated SH-SY5Y cells. Phytother Res. 2014;28:611-6 pubmed publisher

Prinz A, Selesnew L, Liss B, Roeper J, Carlsson T. Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease. Exp Neurol. 2013;248:236-45 pubmed publisher

Lindemann C, Alam M, Krauss J, Schwabe K. Neuronal activity in the medial associative-limbic and lateral motor part of the rat subthalamic nucleus and the effect of 6-hydroxydopamine-induced lesions of the dorsolateral striatum. J Comp Neurol. 2013;521:3226-40 pubmed publisher

Pienaar I, van de Berg W. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats. Exp Neurol. 2013;248:213-23 pubmed publisher

Ren X, Zhang T, Gong X, Hu G, Ding W, Wang X. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model. Exp Neurol. 2013;248:148-56 pubmed publisher

Ciucci M, Schaser A, Russell J. Exercise-induced rescue of tongue function without striatal dopamine sparing in a rat neurotoxin model of Parkinson disease. Behav Brain Res. 2013;252:239-45 pubmed publisher

Tripanichkul W, Jaroensuppaperch E. Ameliorating effects of curcumin on 6-OHDA-induced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice. Eur Rev Med Pharmacol Sci. 2013;17:1360-8 pubmed

Worlitzer M, Viel T, Jacobs A, Schwamborn J. The majority of newly generated cells in the adult mouse substantia nigra express low levels of Doublecortin, but their proliferation is unaffected by 6-OHDA-induced nigral lesion or Minocycline-mediated inhibition of neuroinflammation. Eur J Neurosci. 2013;38:2684-92 pubmed publisher

Ouachikh O, Dieb W, Durif F, Hafidi A. Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area. Behav Brain Res. 2013;252:24-31 pubmed publisher

Petri D, Pum M, Vesper J, Huston J, Schnitzler A. GABAA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat. Behav Brain Res. 2013;252:58-67 pubmed publisher

Blandino P, Hueston C, Barnum C, Bishop C, Deak T. The impact of ventral noradrenergic bundle lesions on increased IL-1 in the PVN and hormonal responses to stress in male sprague dawley rats. Endocrinology. 2013;154:2489-500 pubmed publisher

Tovilovic G, Zogovic N, Soskic V, Schrattenholz A, Kostic Rajacic S, Misirkic Marjanovic M, et al. Arylpiperazine-mediated activation of Akt protects SH-SY5Y neuroblastoma cells from 6-hydroxydopamine-induced apoptotic and autophagic death. Neuropharmacology. 2013;72:224-35 pubmed publisher

Chen H, Li F, Li X, Liu B, Qu F, Wen W, et al. Acute stress regulates nociception and inflammatory response induced by bee venom in rats: possible mechanisms. Stress. 2013;16:557-63 pubmed publisher

Chong C, Zhou Z, Razmovski Naumovski V, Cui G, Zhang L, Sa F, et al. Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Neurosci Lett. 2013;543:121-5 pubmed publisher

Bäck S, Peranen J, Galli E, Pulkkila P, Lonka Nevalaita L, Tamminen T, et al. Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease. Brain Behav. 2013;3:75-88 pubmed publisher

Frau L, Morelli M, Simola N. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons. Exp Neurol. 2013;247:663-72 pubmed publisher

López Huerta V, Carrillo Reid L, Galarraga E, Tapia D, Fiordelisio T, Drucker Colín R, et al. The balance of striatal feedback transmission is disrupted in a model of parkinsonism. J Neurosci. 2013;33:4964-75 pubmed publisher

Hernandez L, Kubota Y, Hu D, Howe M, Lemaire N, Graybiel A. Selective effects of dopamine depletion and L-DOPA therapy on learning-related firing dynamics of striatal neurons. J Neurosci. 2013;33:4782-95 pubmed publisher

Reinhardt P, Schmid B, Burbulla L, Schöndorf D, Wagner L, Glatza M, et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell. 2013;12:354-67 pubmed publisher

Dil mukhametova L, Pronina T, Ugriumov M. [Noradrenaline role in regulation of dopamine-producing neurons in rat arcuate nucleus]. Ross Fiziol Zh Im I M Sechenova. 2012;98:1507-19 pubmed

Wang Y, Wang X, Li R, Yang Z, Wang Y, Gong X, et al. A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons. CNS Neurosci Ther. 2013;19:183-90 pubmed publisher

Padovan Neto F, Ferreira N, de Oliveira Tavares D, de Aguiar D, da Silva C, Raisman Vozari R, et al. Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/deltaFosB expression. Neurosci Lett. 2013;541:126-31 pubmed publisher

Jalali Nadoushan M, Roghani M. Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism. Brain Res. 2013;1505:68-74 pubmed publisher

Mansouri M, Farbood Y, Sameri M, Sarkaki A, Naghizadeh B, Rafeirad M. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem. 2013;138:1028-33 pubmed publisher

Ahmad A, Maruyama T, Narumiya S, DORE S. PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target. Neurotox Res. 2013;23:260-6 pubmed publisher

Thomas Tayra J, Kameda M, Yasuhara T, Agari T, Kadota T, Wang F, et al. The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease. Brain Res. 2013;1502:55-70 pubmed publisher

Abedi P, Delaville C, De Deurwaerdere P, Benjelloun W, Benazzouz A. Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat. Neuroscience. 2013;236:289-97 pubmed publisher

Heuer A, Lelos M, Kelly C, Torres E, Dunnett S. Dopamine-rich grafts alleviate deficits in contralateral response space induced by extensive dopamine depletion in rats. Exp Neurol. 2013;247:485-95 pubmed publisher

Kobylecki C, Crossman A, Ravenscroft P. Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia. Exp Neurol. 2013;247:476-84 pubmed publisher

Haleagrahara N, Siew C, Ponnusamy K. Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats. J Toxicol Sci. 2013;38:25-33 pubmed

Kabuto H, Yamanushi T, Janjua N, Takayama F, Mankura M. Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model. J Oleo Sci. 2013;62:21-8 pubmed

Ribeiro R, Moreira E, Santos D, Colle D, dos Santos A, Peres K, et al. Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease. Neurochem Res. 2013;38:660-8 pubmed publisher

Lin L, Meng T, Liu T, Zheng Z. Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease. Life Sci. 2013;92:311-6 pubmed publisher

Chao O, Pum M, Huston J. The interaction between the dopaminergic forebrain projections and the medial prefrontal cortex is critical for memory of objects: implications for Parkinson's disease. Exp Neurol. 2013;247:373-82 pubmed publisher

Chotibut T, Apple D, Jefferis R, Salvatore M. Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake. PLoS ONE. 2012;7:e52322 pubmed publisher

Kaddour H, Hamdi Y, Vaudry D, Basille M, Desrues L, Leprince J, et al. The octadecaneuropeptide ODN prevents 6-hydroxydopamine-induced apoptosis of cerebellar granule neurons through a PKC-MAPK-dependent pathway. J Neurochem. 2013;125:620-33 pubmed publisher

Seeger Armbruster S, von Ameln Mayerhofer A. Short- and long-term unilateral 6-hydroxydopamine lesions in rats show different changes in characteristics of spontaneous firing of substantia nigra pars reticulata neurons. Exp Brain Res. 2013;224:15-24 pubmed publisher

Xu Y, Long L, Yan J, Wei L, Pan M, Gao H, et al. Simvastatin induces neuroprotection in 6-OHDA-lesioned PC12 via the PI3K/AKT/caspase 3 pathway and anti-inflammatory responses. CNS Neurosci Ther. 2013;19:170-7 pubmed publisher

Grespi F, Melino G. P73 and age-related diseases: is there any link with Parkinson Disease?. Aging (Albany NY). 2012;4:923-31 pubmed

Lui N, Chen L, Yung W, Chan Y, Yung K. Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat Parkinsonism. PLoS ONE. 2012;7:e51294 pubmed publisher

Shalavadi M, Chandrashekhar V, Avinash S, Sowmya C, Ramkishan A. Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson's disease model. Indian J Pharmacol. 2012;44:737-43 pubmed publisher

Xue Y, Bai B, Yung W, Chen L. Electrophysiological effects of neurotensin on globus pallidus neurons of 6-hydroxydopamine-lesioned rats. Neurosignals. 2009;17:153-61 pubmed publisher